Adverse Effects of Remdesivir for the Treatment of Acute COVID-19 in the Pediatric Population
Abigail Schulz,
Natalie Huynh,
Margaret Heger
et al.
Abstract:Background: Although the severity of Coronavirus Disease 2019 (COVID-19) tends to be lower in children, it can still lead to severe illness, particularly among those with chronic medical conditions. Remdesivir (RDV) is the only U.S. Food and Drug Administration-approved antiviral treatment for high-risk patients >28 days old. However, the available data on the safety of RDV in children is limited.
Methods: To address this knowledge gap, a multicenter study involving 65 patients retrospectively analyzed the … Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.